Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

The FDA announced that the tirzepatide injection shortage is resolved ... and has ended as manufacturing capacity and product availability are sufficient to meet national demand.

Eli Lilly’s request to intervene in a suit filed by compounding pharmacies against the FDA reflects a belief the outcome ...

Specializing in cutting-edge treatments like Semaglutide and Tirzepatide, Zest Meds has positioned itself as a leader in the weight loss industry. Their approach is simple yet effective ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering glucose levels and body weight. At the Cardiometabolic Health Congress ...

Availability of services: Weight management services are ... be safely implemented within 3 months because there is insufficient capacity to deliver tirzepatide in primary care. To meet this resource ...

But the group's members are still reporting that "there's a real lack of availability" of tirzepatide, she said. That trade group represents compounding pharmacies and hybrid pharmacies that also ...

Cost and availability: Tirzepatide is newer to the market and may be less widely available or more expensive than semaglutide. Side effects: Both medications share common side effects like nausea ...